Quest Diagnostics (DGX) Interest Expenses (2009 - 2026)

Quest Diagnostics has reported Interest Expenses for 18 years, with the latest figure at $107.0 million in Q2 2026.

• Quarterly Interest Expenses fell 5.31% year-over-year to $107.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $311.0 million (up 73.74% YoY) and the FY2025 annual result came in at $823.0 million, down 2.49% from the prior year.
• Interest Expenses rose to $107.0 million in Q2 2026 per DGX's latest filing, from $65.0 million in the prior quarter.
• Over five years, Interest Expenses peaked at $367.0 million in Q1 2022 and troughed at -$68.0 million in Q4 2024.
• A 5-year average of $109.7 million and a median of $69.5 million in 2025 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2024 and 2025: Interest Expenses slumped 190.67% in 2024, then surged 202.94% in 2025.
• Over 5 years, Interest Expenses stood at $73.0 million in 2022, then advanced by 2.74% to $75.0 million in 2023, then plunged by 190.67% to -$68.0 million in 2024, then soared by 202.94% to $70.0 million in 2025, then soared by 52.86% to $107.0 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $107.0 million, $65.0 million, and $70.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.